Bristol-Myers Squibb Co.

In News

Lobbying Update: $1,320,000 of BRISTOL-MYERS SQUIBB COMPANY lobbying was just disclosed - Quiver Quantitative

Quiver Quantitative - Apr 21, 2026

Bristol Myers vs Gilead Sciences: Which Biotech Stock Is a Better Bet Now? - TradingView

TradingView - Apr 21, 2026

Bristol Myers Squibb Co. stock underperforms Monday when compared to competitors - MarketWatch

MarketWatch - Apr 20, 2026

Foundation Medicine Expands Existing Collaboration with Bristol Myers Squibb to Develop a Next-Generation Sequencing Companion Diagnostic to Identify Patients with Homozygous MTAP Deletion - Yahoo Finance UK

Yahoo Finance UK - Apr 21, 2026

Assetmark Inc. Lowers Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat

MarketBeat - Apr 18, 2026

Bristol-Myers Squibb Company Solicits Proxies from Shareholders - marketscreener.com

marketscreener.com - Apr 17, 2026

BMY Technical Analysis | Trend, Signals & Chart Patterns | BRISTOL-MYERS SQUIBB CO (NYSE:BMY) - ChartMill

ChartMill - Apr 17, 2026

New Bain biotech startup, building on BMS drugs, gets a name and a CEO - statnews.com

statnews.com - Apr 15, 2026

Bain Capital’s Beeline Medicines Emerges With Assets From Bristol Myers Squibb - citybiz

citybiz - Apr 16, 2026

US FDA approves Bristol Myers Squibb's cancer drug for Hodgkin's lymphoma - Reuters

Reuters - Mar 20, 2026

Protein homeostasis 101: A Q&A with Mark Rolfe - Bristol Myers Squibb

Bristol Myers Squibb - Jan 28, 2026

Bristol Myers Squibb Company $BMY Shares Sold by Mirae Asset Global Investments Co. Ltd. - MarketBeat

MarketBeat - Apr 17, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment